Chemoinformaics analysis of 2,5,9-Trimethylcycloundeca-4,8-dienone
Molecular Weight | 206.329 | nRot | 0 |
Heavy Atom Molecular Weight | 184.153 | nRig | 12 |
Exact Molecular Weight | 206.167 | nRing | 1 |
Solubility: LogS | -4.147 | nHRing | 0 |
Solubility: LogP | 3.122 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 38.8514 |
nHD | 0 | BPOL | 22.9386 |
QED | 0.546 |
Synth | 3.794 |
Natural Product Likeliness | 2.229 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.284 |
Pgp-sub | 0.004 |
HIA | 0.045 |
CACO-2 | -4.572 |
MDCK | 0.0000232 |
BBB | 0.742 |
PPB | 0.949118 |
VDSS | 0.786 |
FU | 0.0139643 |
CYP1A2-inh | 0.395 |
CYP1A2-sub | 0.597 |
CYP2c19-inh | 0.213 |
CYP2c19-sub | 0.333 |
CYP2c9-inh | 0.123 |
CYP2c9-sub | 0.902 |
CYP2d6-inh | 0.102 |
CYP2d6-sub | 0.792 |
CYP3a4-inh | 0.134 |
CYP3a4-sub | 0.197 |
CL | 6.515 |
T12 | 0.796 |
hERG | 0.006 |
Ames | 0.003 |
ROA | 0.005 |
SkinSen | 0.892 |
Carcinogencity | 0.035 |
EI | 0.804 |
Respiratory | 0.04 |
NR-Aromatase | 0.008 |
Antiviral | Yes |
Prediction | 0.715995 |